Fig. 3From: Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case reportThermoFisher VIRSNiP assay (ThermoFisher, Waltham, Massachusetts, USA) results. No amplification for the negative control; wild type samples (E484E) segregate on the low right; E484K samples segregate at the top; sample collected from our patient is observed in an intermediate location between wild type samples and E484K samplesBack to article page